Swab and Viral Transport Medium Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2030

The global swab and viral transport medium market is estimated to exhibit a CAGR of 1.2 % over the forecast period 2020-2030, according to a new research by Future Market Insights (FMI).

An upswing in the sales of critical equipment with respect to collection and transportation of samples is currently underway. This has escalated the production of swab and viral transport medium, thereby driving the market.

To detect the viral RNA in human body; nasopharyngeal swab and deep nasal swab techniques are being used. The overall market is primarily driven by increased rate of flu in various regions. As per CDC, 2019-20 season has witnessed close to 20 Mn cases of influenza in the U.S. with 280,000 hospitalizations as on Feb 15, 2020.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-11195

At the same time, efforts taken by respective governments to increase awareness about flu, coupled with initiatives undertaken by World Health Organization (WHO), Global Alliance for Vaccines and Immunization (GAVI), The Pan American Health Organization (PAHO), etc. are expected to drive the market.

“Expanded Program on Immunization” is one the initiatives taken by PAHO at the pan American level. In Jan 2020, GAVI, at the behest of MSF (Doctors without Borders) bulk brought cheaper pneumococcal vaccine for around 55 Mn children. The initiatives mentioned above would be taken up in the forecast period as well. That will certainly ask for more swab and viral transformation motion to be in place.

Key Takeaways from Swab and Viral Transport Medium Market Study

  • The global market for swab and viral transport medium is showing sharp increment in the year 2020 due to outbreak of Covid-19 with increase in demand for pool of patients going for certain diagnostic tests.
  • Based on symptoms, influenza, coronavirus, and hanta virus are expected to collectively hold more than 50% of revenue in the year 2020.
  • Among all end users, diagnostic laboratories are anticipated to witness a CAGR of 1.6% over the forecast period.
  • North America and Europe collectively accounted for more than 70% of revenue share in 2019 while Asia Pacific is expected to show greater growth potential over the forecast period.
  • Asia Pacific is expected to upturn the swab and viral transport medium market in the years to come with local players going for in-house swabs

New Product Launches: Key Strategic Focus Area of Swab and Viral Transport Medium Market Players

New product launches/approvals and governments’ support are raising the bar for competition amongst market players. Numerous organizations are focusing on new product launches for diagnostic test especially for coronavirus and influenza. For Instance, DiaSorin, a prominent manufacturer of swabs specifies NP swabs in 3 ml of Copan Universal Transport Media (UTM) or BD Viral Transport Media. In 2019, MWE launched ∑-VCM™ transport device, to enable the collection, transport and preservation of viruses.

The other players included as a part of market study include McKesson Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation, COPAN Diagnostics Inc., VIRCELL S.L., Deltalab, and Medical Wire & Equipment (MWE).

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11195

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Chitosan Market Growth will continue especially in response to the rising demand for non-GMO and clean label ingredients, Says FMI Analyst

Chitosan is a highly sought-after for application in the food and beverages, pharmaceutical, and other sectors due to its biocompatibility, low toxicity, and high percentage of amino groups that confer unique functionalities, such as antimicrobial activity and wound healing acceleration.

According to a study by Future Market Insights (FMI), the chitosan market is forecast to reach a valuation of US$ 1.03 Bn by 2021. Growth will continue especially in response to the rising demand for non-GMO and clean label ingredients within the food sector.

As per the study, sales within dietary supplements segment will amplify at an impressive pace, accounting for over 36% of the market in 2021. The trend will continue well into the forthcoming years, as consumers from around the world show greater inclination towards a healthy lifestyle.

Consumption of chitosan in powder form is more than in liquid form. The increasing applications of powder chitosan in dietary supplements, cosmetics, and other sectors will seal dominance of powder chitosan in the market.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11443

Key Takeaways from the Chitosan Market Study

  • The global chitosan market is expected to rise at 14.3% CAGR between 2021 and 2031
  • Increasing demand for dietary supplements will spur sales in the U.S., sealing its dominance in the North America market with a share of above 83% in 2021
  • Increasing focus on health and wellness will drive sales in the U.K., enabling it to register y-o-y growth at 10.3% in 2021
  • Increasing application in pharmaceutical sector will be a chief growth driver in Germany and France
  • Increasing focus on Non-GMO and clean label ingredients will seal Japan’s dominance in the East Asia market

“There is increasing focus on product launches in the global market. This trend will continue as competition gets fiercer in the coming years. Consequently, the market will exhibit increasing investment in research and development,” said a lead analyst at FMI

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11443

Increasing Application in Sports Nutrition Driving Growth

Sports nutrition products are becoming more popular, particularly among athletes and those who participate in demanding physical activity. Some of the important causes propelling the sports nutrition sector are growing focus on being in shape and maintaining a healthy body, as well as greater involvement in fitness, health clubs, sports clubs, and gyms.

Due to an increase in health concerns and changes in lifestyle, fitness centers and health clubs have seen impressive growth in recent years. With the rise in awareness regarding health and the need for proper dietary content in food, the market for health & fitness nutrition products infused with natural ingredients like chitosan has grown.

Who is winning?

Some of the leading companies offering chitosan are Agratech (KYTOSAN USA, LLC), Austanz Chitin Pty Ltd., CarboMer, Inc., Golden-Shell Pharamceuticals Co. Ltd, Heppe Medical Chitosan GmbH, KIMICA Corporation, Kitozyme, LLC., Kraeber & Co. GmbH, Meron Group, Qingdao Haijia Biology and Technology Co. Ltd, Tidal Vision Inc., Chitolytic, Marshall Marine Products, Zhejiang Aoxing Biotechnology Co. Ltd.,

Chitosan manufacturers are focusing on introducing innovative products in the market. The manufacturers are also focusing on research & development activity to cater the emerging demand from customer in the established and emerging markets.

Get Valuable Insights into Chitosan Market

Future Market Insights, in its new offering, provides an unbiased analysis of the Chitosan market presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the Chitosan market based on form (liquid and powder), by source (shrimp, crab and lobster), and by end use (food additives, dietary supplements, pharmaceuticals & biomedical and cosmetics & personal care) across seven major regions.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-11443

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Specialty Mint Oils Market 2021 Industry Research, Segmentation, Key Players Analysis and Forecast to 2029

The Specialty mint oils are extracted from various flowers and stem of the mint herb.  Steam distillation is the process utilized for the extraction of specialty mint oils. Specialty mint oils are sweet-scented. In Greek mythology, mint is known as “the herb of hospitality. Specialty mint oils are mainly used in deodorants and room freshener sprays. Various flavors are available in specialty mint oils pennyroyal, peppermint, spearmint, and wintergreen, among others. Specialty mint oils are used widely in the oral products due to its cooling effect and specialty mint oils have the capability to easily kill the bacteria which prevent the bad breath. The demand for oral products is increasing rapidly which will boost the demand for specialty mint oils. Specialty mint oils are used in food and beverage industry for adding flavor and smell.

GRAS (Generally recognized as safe) tag is achieved by specialty mint oils. The importance of FDA approval is growing in all industries. Specialty mint oils are used across all end-user industries as it is generally recognized as a safe tag which is boosting the sale of specialty mint oils. Increasing demand for specialty mint oils and a growing number of manufacturers all over the world are the reasons for increasing the competitive level in the specialty mint oils market. To save the position in specialty mint oils market manufacturers are producing unique & innovative products in the specialty mint oils market with attractive offerings.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9766

Specialty Mint Oils Market: Regional Analysis:

North-America and Europe hold maximum share in terms of market value in the specialty mint oils. North-America is leading in the manufacturing of the specialty mint oils. Europe is leading to the production of peppermint. The food applications are growing rapidly which will boost the demand for specialty mint oils as it is an important ingredient for adding flavor in the food. The increasing investment in pharmaceutical and personal care industry is helping for the growth of specialty mint oils market. Asia-Pacific and Latin America are anticipated to project a high growth rate in the forecasted period due to the rapid growth of the food industry in this region.

Specialty Mint Oils Market: Key Participants:

  • Lebermuth
  • Aromatic and Allied Chemicals
  • AOS Products
  • Hindustan Mint and Agro Products
  • Arora Aromatics
  • Bhagat Aromatics
  • De Monchy Aromatics
  • Vinayak Ingredients
  • Foodchem International
  • Shanti Chemicals
  • Paras Perfumers
  • Essex Laboratories
  • Elixarome

The report covers exhaustive analysis on:

  • Specialty mint oils market Segments
  • Specialty mint oils market Dynamics
  • Specialty mint oils market Size
  • Specialty mint oils Supply and Demand
  • Current Trends/Issues/Challenges pertaining to specialty mint oils market
  • Competition Landscape and Emerging Market Participants in specialty mint oils market
  • Technology related to Production/Processing of specialty mint oils.
  • Value Chain Analysis of the specialty mint oils market

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9766

Specialty Mint Oils Market Segmentation:

On the basis of form, the specialty mint oils market is segmented into:

  • Oral products
  • Confectionary products
  • Pharmaceutical products
  • Tobacco products
  • Fragrance products

On the basis of end use, the specialty mint oils market is segmented into:

  • Food Industry
  • Pharmaceutical Industry
  • Cosmetics Industry
  • Personal Care
  • Skin & Hair Creams
  • Massage
  • Aromatherapy
  • Cosmetics
  • Nail Care

Report Highlights:

  • Detailed overview of parent market
  • Changing dynamics of the specialty mint oils market in the industry
  • In-depth market segmentation and analysis
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments in the specialty mint oils market
  • Competitive landscape of the specialty mint oils market
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on specialty mint oils market performance
  • Must-have information for specialty mint oils market players to sustain and enhance their market footprint

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/9766

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

RT-PCR Kits Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

RT-PCR kits are finding extensive applications on the back of factors such as the rising incidences of infectious diseases and genetic disorders. As technological advancements continue to empower the RT-PCR kits, coupled with increasing investments in research and development activities, the market is witnessing positive growth.

COVID-19 Pandemic to Remain Key Growth Influencer in Near Term

While the market is set for gradual growth in the foreseeable future, the recent outbreak of COVID-19, which has metamorphosed into a global pandemic is certain to assert influence on the market. Moreover, there is a continual demand for effective detection techniques on the back of rising cases of major infectious diseases such as HIV, tuberculosis, malaria, hepatitis, and Staph-related diseases, and genetic disorders such as cancer and syndromes. For instance, according to the World Health Organization, approximately 219 million cases of malaria were reported around the world in the year 2018, with 92% cases in the African subcontinent alone. Statistics such as these significantly propel the demand for the RT-PCR kits.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-11196

RT-PCR Kit – A Highly Sought-out Methodology

Reverse Transcription-Polymerase Chain Reaction (real-time RT-PCR) is a nuclear-based method, used to detect the presence of genetic materials such as pathogens, viruses, and microorganisms, among others. Regardless of where the contamination is, RT-PCR kits will detect the foreign body. The increasing adulteration of food products and the growing need for accurate diagnosis are creating potential growth opportunities for real-time PCR system manufacturers. A kit using the real-time RT-PCR method is considered one of the most accurate methods to track, detect, and study contagious viruses such as the coronavirus.

Furthermore, the RT-PCR technique is capable of delivering accurate diagnosis at a quick turnaround time, usually half the time it takes in laboratories. With the mounting cases of COVID-19 around the world, the need for quick and efficient testing is intensifying and the RT-PCR kit is the most sought-out methodology in the health-care industry, thereby creating a spike in the demand for these kits.

North America Exhibits Dominance Backed by High Adoption Rate; Europe Follows Closely  

North America is currently dominating the global RT-PCR kit market and is expected to maintain its supremacy in the future. The region is invigorated by factors such as high spending on healthcare, increased adoption of the novel kits, availability of R&D grants, and commercialization of the kits. Closely following North America is Europe, which is the second most lucrative region for manufacturers in the RT-PCR kit market, backed by the healthy presence of testing laboratories, research facilities, and pharmaceutical industries. Likewise, Asia Pacific is also expected to create substantial revenue opportunities owing to the investments in the research and development sector in the emerging economies.

Competitive Landscape of RT-PCR Kits Market

Some of the key players in the RT-PCR kit market are F. Hoffman-La Roche Ltd., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V,, Takara Bio, Inc., Agilent Technologies, Inc., Biomérieux S.A., Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Eppendorf AG, Analytik Jena AG, Meridian Bioscience, Inc., Enzo Life Sciences, Inc., Cole-Parmer Instrument Company Llc, and Bioneer Corporation among others. With mounting cases of COVID-19 and sky-rocketing demand, the market players are racing to expand profit pools.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11196

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Granulated Sugar Market 2021 Key Players, End User, Demand and Consumption by 2029

Granulated sugar is a rich source of carbohydrates which soluble in nature. The sugar is made up of various sources like sugarcane, sugar beet, date palm, sorghum, and sugar maple, etc. For the production of sugar, sugarcane is widely used as a raw material across the globe. The industrial sugar is classified into powdered, granulated and syrup on the basis of product. The granulated sugar is also known as white sugar. Granulated sugar is used in the food & beverage industry, bakery and confectionery; it is a primary ingredient in the food & beverage industry. The demand for food applications is increasing rapidly all over the world which is growing demand for granulated sugar market. The number of players participating in granulated sugar industry is increasing. The increasing demand for granulated sugar and a growing number of manufacturers all over the world are the reasons for increasing the competitive level in the market. To save the position in granulated sugar market manufacturers are producing unique & innovative products in the market with attractive offerings.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9789

Granulated Sugar Market: Regional Analysis:

Asia-Pacific is leading in the production of granulated sugar and it is expected to increase the production and plantation of sugarcane in the forecasted period. In Asia-Pacific mainly India, China, Indonesia are the producers of granulated sugar. Europe is dominating the production of beet sugar. The North-America is also expected to increase the production of granulated sugar in the near future

 Granulated Sugar Market: Key Participants: 

  • Sudzucker
  • C&H Sugar
  • Lotus Health Group
  • Ganzhiyuan
  • Archer Daniels Midland Company
  • Nordzucker Group AG
  • Wilmar International Ltd
  • Illovo Sugar Ltd
  • Cargill
  • Wholesome Sweeteners
  • Nordic Sugar A/S
  • D Parry Limited
  • Wilmar International Ltd
  • Mitr Phol Sugar Corp
  • Nordzucker Group AG, Cosan SA
  • Suedzucker AG

The report covers exhaustive analysis on:

  • Granulated sugar market Segments
  • Granulated sugar market Dynamics
  • Granulated sugar market Size
  • Granulated sugar Supply and Demand
  • Current Trends/Issues/Challenges pertaining to granulated sugar market
  • Competition Landscape and Emerging Market Participants in granulated sugar market
  • Technology related to Production/Processing of granulated sugar.
  • Value Chain Analysis of the granulated sugar market.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9789

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

 Granulated Sugar Market: Segmentation 

On the basis of source, the granulated sugar market is segmented into:

  • Sugarcane
  • Sugar beet
  • Date palm
  • Sorghum
  • Sugar maple
  • Others

On the basis of product, the granulated sugar market is segmented into:

  • Soft sugar
  • Crystal sugar
  • Others

On the basis of end use, the granulated sugar market is segmented into:

  • Bakery Industry
  • Beverage Industry
  • Confectionery & Ice-Cream Industry
  • Pharmaceutical Industry
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing dynamics of the granulated sugar market in the industry
  • In-depth market segmentation and analysis
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments in granulated sugar market
  • Competitive landscape of the granulated sugar market
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective granulated sugar market performance
  • Must-have information for granulated sugar market players to sustain and enhance their market footprint.

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/9789

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Oxytocin Market Perspective, Comprehensive Analysis, Growth and Forecast 2020-2030

ESOMAR certified consulting firm Future Market Insights (FMI) has recently published an exhaustive yet unbiased report on the global oxytocin market, highlighting the prominent parameters responsible for steering growth in the long-run. The study opines global oxytocin sales to grow at over 8% through 2030, with growing focus on preventing PPH incidences expected to drive demand.

While the frequency of childbirths is increasing, the number of complications faced by women are also compounding. The Center for Disease Control and Prevention estimates that over 50,000 women across the U.S endure life-threatening complications.

Consequently, healthcare providers are incorporating solutions aimed at reducing trauma faced by patients which include numerous approaches. A common complication faced by women is postpartum hemorrhage, for which oxytocin treatment is a highly preferred option. A value CAGR exceeding 8% is projected for the market through 2030.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-11218

Key Takeaways

  • Postpartum hemorrhage (PPH) solutions to comprise nearly 90% of the revenue share in 2020 by product type
  • Hospital pharmacies remain key distribution channels, online pharmacies’ popularity to widen
  • Opportunities abound across the Middle East & Africa (MEA) owing to rising PPH incidence in Africa
  • Global oxytocin market is projected to reach US$ nearly US$ 165 Mn by 2030

COVID-19 Impact Analysis

As the COVID-19 pandemic intensified, the global medical fraternity is facing immense challenges as resources are being redirected towards eradicating the deadly virus. Consequently, other treatment areas have been relegated to the backseat, including maternity care. This is a cause of concern amongst leading healthcare specialists.

Therefore, efforts are being made towards ensuring adequate and proper treatment to pregnant women across all regions. Furthermore, oxytocin has also been touted as an effective anti-viral agent, thus raising optimism that it could be effectively leveraged to promote drug or vaccine development.

The National Center for Biotechnology Information hypothesizes that oxytocin contains dipeptidyl peptidase-4 (DPP4) protease inhibitors could be effective against the existing novel coronavirus strain. It further propagates that enhancing endogenous oxytocin levels could increase viral resistance and improve health of vulnerable groups.

Competitive Landscape

Prominent players in the global oxytocin market include Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International Plc. (Par Sterile Products, LLC), Teva Pharmaceuticals Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd. and Yuhan Corporation.

The market is highly fragmented, peppered with numerous regional and global level market players. These players largely concentrate on forging strategic collaborations with existing players, regional distributors, product launches and acquisitions. Most players are concentrating on offering anesthetic oxytocin solutions to reduce labor induced complications for C-section operations.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11218

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Pharmaceutical Surfactants Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2030

Surfactants are commonly used in pharmaceuticals for recovery of intracellular products and gene delivery. Pharmaceutical surfactants can also be used as an antimicrobial agent. The surfactants can be categorized in different type’s anionic surfactants, cationic surfactants, non-ionic surfactants, amphoteric surfactants, speciality surfactants, macromolecule surfactants, Gemini surfactants and natural surfactants. The non-ionic surfactants are used in pharmaceuticals for protein formulations. Bio-surfactants are extensively used in the pharmaceutical industry for drug delivery, act as an adhesive agent, and therapeutic agent because of their antibacterial, antifungal and antiviral activities. Gemini surfactants used as a transfection agent for drug delivery and one of the most active areas of research. However, according to FDA nonclinical and clinical studies are essentially required before use of pharmaceutical surfactants. Besides, there is a growing interest in pharmaceutical surfactants because of their high surface activities and major role in immunomodulation. Due to their unique properties pharmaceutical surfactants plays a special physiological role in maintaining the alveolar structure during normal lung respiration. Also, respiratory problems in neonates due to the alveolar surfactant deficiency is one of the major factor expected to boost the pharmaceutical surfactants market growth. In recent years the emergence of respiratory distress syndrome due to the damage of surfactants evolved the surfactant replacement therapy as a well-established treatment modality. Manufacturers are constantly looking for new product development and providing services to expand their business in pharmaceutical surfactants market over forecast periods. However strict regulatory guidelines for pharmaceutical surfactants product launch and use may restrain the pharmaceutical surfactants market growth during forecast periods.

Pharmaceutical Surfactants Market: Drivers and Restraints

The unique property of emulsification and Solubilisation of pharmaceutical surfactants for protein formulations and drug delivery is expected to propel the pharmaceutical surfactants market growth. The growing market for pharmaceutical products and cosmetics is also expected to accelerate the pharmaceutical surfactants market growth. The rise in the pharmaceutical industry and growing demand for pharmaceutical products also anticipated boosting the pharmaceutical surfactants market growth. However, stringent regulatory policies may hamper pharmaceutical surfactants market growth. Nevertheless growing demand for pharmaceutical surfactants can create huge growth opportunities for the market players operating in pharmaceutical surfactants market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-11252

Pharmaceutical Surfactants Market: Overview

The global pharmaceutical surfactants market is expected to grow high during forecast years owing to its increasing application in the field of cosmetics and medicine. Increasing incidences of respiratory distress syndrome are expected to propel the pharmaceutical surfactants market growth. The antimicrobial properties of pharmaceutical surfactants are also expected to boost the demand for pharmaceutical surfactants in the forecast periods. The importance of pharmaceutical surfactants in immunomodulation, drug delivery and protein formulation is providing huge opportunities to the market players to develop new products and increase their product portfolio in pharmaceutical surfactants market.

Pharmaceutical Surfactants Market: Region-wise Outlook

Geographically, U.S. is expected to contribute the highest revenue share in pharmaceutical surfactants market owing to its increasing funding towards research and development and clinical trial activities and increasing demand of pharmaceutical surfactants in cosmetic industries followed by Europe. Considerable growth is expected in the Asia Pacific due to the growing economy and growing pharmaceutical industries in this region. However, the growing population and increasing demand for pharmaceuticals in the Asian countries like India and China is expected to be the target region for the market players operating in pharmaceutical surfactants market.

Pharmaceutical Surfactants Market: Key Market Participants

The key players of the global pharmaceutical surfactants market include Akzo Nobel N.V., Evonik, Croda International Plc. BASF SE, Jeneil Biotech, Mitsubishi Chemical Corporation, Soliance, S.A., Jeneil Biotech and Ecover, among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11252

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Nutrigenomic Market 2021 Key Players, SWOT Analysis, Key Indicators and Forecast to 2029

Nutrigenomics is a novel technology that is designed to build the gap between nutrition and advanced genetics. Nutrigenomics is a tool that is developed for medical professionals to understand the consumer’s metabolic needs and then recommend the nutritional supplements accordingly. Nutrigenomics allows a personalized nutritional recommendation for an individual. Nutrigenomics focuses on Single Nucleotide Polymorphisms (SNPs) that account for 90% of the variation in the human genome. Nutrigenomics uses tools such as biomarkers, clinical data, and genomic assays. Nutrigenomics helps to identify the chances of occurrence of a disease and enables to get personalized treatment for it. Nutrigenomics has applications in hospitals, research organizations, dietary supplement industry, pharmaceutical industry, etc.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9787

Increasing Demand for Personalized Products is Propelling the Nutrigenomics Market

The increase in the prevalence of diabetes, other chronic diseases is anticipated to increase the demand for nutrigenomics. According to the World Health Organization, in 2016, approximately 1.6 million deaths occurred due to diabetes and was the seventh leading cause of death in the world. Chronic diseases are the major cause of death all across the globe. By 2020, the chronic diseases are anticipated to rise up to 73% of the total deaths. The most common chronic diseases are cardiovascular diseases, cancer, and diabetes. As the health-awareness is increasing, the consumers are willing to pay more so as to live a healthy lifestyle. The demand for personalized products is anticipated to increase to reduce the risk of diseases and disorders. The demand for personalized products is anticipated to boosts the demand for nutrigenomics.

Nutrigenomics Market: Key Participants

Some of the key market players in the nutrigenomics market are:

  • GX Sciences, Inc
  • Nutrigenomix
  • NutraGene
  • Cura Integrative Medicine
  • Metagenics, Inc
  • XCODE Life Sciences Pvt. Ltd.
  • Nutrigenomics New Zealand
  • Ora Organic

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9787

The report covers exhaustive analysis on:

  • Nutrigenomics Market Segments
  • Market Dynamics
  • Market Size
  • Supply and Demand
  • Current Trends/Issues/Challenges pertaining to nutrigenomics market
  • Competition Landscape and Emerging Market Participants in nutrigenomics market
  • Technology related to Production/Processing of nutrigenomics
  • Value Chain Analysis of the nutrigenomics market

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Nutrigenomics Market Segmentation

The nutrigenomics market can be segmented on the basis of end-use-

On the basis of end-use, the nutrigenomics market can be segmented as:

  • Food and Beverage
  • Pharmaceutical
  • Functional Foods and Dietary Supplement
  • Hospitals
  • Academic and Research Organizations

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/9787

Report Highlights:

  • Detailed overview of parent market
  • Changing dynamics of the nutrigenomics market in the industry
  • In-depth market segmentation and analysis
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments in the nutrigenomics market
  • Competitive landscape of the nutrigenomics market
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on nutrigenomics market performance
  • Must-have information for nutrigenomics market players to sustain and enhance their market footprint

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Lab Confirmation Tetsing Kit Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2030

This Lab Confirmation Testing Kit market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Lab Confirmation Testing Kit market.

COVID-19, also known as coronavirus disease, is continuing to spread globally with confirmed cases now surpassing 9,60,000 cases. With skyrocketing confirmed incidences of COVID-19, pharma, healthcare workers, universities as well as institutes are working tirelessly day and night to discover or develop cure for the life-threatening virus.

A point of contention at this critical hour is testing rates. It is only through widespread testing that the spread of this lethal virus and other metrics such as infectiousness and mortality rates, can be effectively recorded. Thus, readily available test kits are an indispensable way of effectively fighting and curbing the pandemic.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-11270

WHO’s Initiative in Controlling the Situation

Aiming to identify research gaps and priorities for COVID-19, collaborating with GloPID-R, WHO has organized a Forum on 11-12 February, 2020. The Forum has recognized urgent need for access to accurate and standardized diagnostics for SARS-CoV-2 (the causative agent of COVID-19), deployable in decentralized settings, has been recognized as one of the eight immediate research needs.

The Centers for Disease Control and Prevention (CDC), the US agency charged with tracking and investigating public health trends, is working in close co-operation with private labs to make more tests available. According to health experts, such an initiative would help capacitate to complete about 100 tests per day, which isn’t proportionate to the spread of this virus.

The Urgent Need for Diagnostic Kits

At this point of time, an effective and efficient diagnosis of this alarmingly spreading virus would immensely help in curbing its spread all around the world. Developing a widely accessible, inexpensive point-of-care diagnostic kit requires an accountable leadership, decisive science-based governance, significant financing, and the application of reliable principle-based scientific protocols to determine whom to test, how to interpret results, and how best to treat and quarantine those infected.

Such measures would not only help contain the current COVD-19 epidemic; it can also create a system for developing similar tools to stop future pandemics. Thus, by taking the lead in creating such an infrastructure, the US can help itself and the rest of the world as well. According to Mediheroes, made-in-Korea diagnostic kits that have not won FDA’s emergency use authorization are likely to be used in USA.

Lab Confirmation Kits Being Developed by Various Companies

Numerous companies are racing to develop diagnostic kits – a new diagnostic tools identified by the Foundation for Innovative Diagnostics, a fifteen-minute test being developed by Chinese laboratories, a Duke University test being deployed in Singapore and diagnostic tests by CRISPR technology are a few noteworthy mentions. The US Food and Drug Administration (FDA) has an accelerated pathway for “emergently needed” diagnostic tools, but relies on developers need to conduct or sponsor themselves.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11270

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

BRCA Mutation-Positive Ovarian Cancer Market 2020: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2030

A patient with high grade serious ovarian cancer who carry germline mutations in BRCA 1/2 genes is known as BRCA mutation-positive ovarian cancer. BRCA gene mutations lead to a majority of ovarian and breast cancer cases globally. Genetic screening for BRCA mutations in patients has helped researchers for improved preventive measures and therapeutic development. According to CDC data, In U.S. nearly 70,000 new patients suffer from ovarian cancer every year. Most patients are diagnosed at advance stages making it difficult to treat them.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-11267

BRCA Mutation-Positive Ovarian Cancer Market: Drivers and Restraints

Increasing incidence of ovarian cancers with BRCA mutations globally is expected to drive the BRCA mutation-positive ovarian cancer market. Advanced and early genetic screening of BRCA mutations in general population will drive the BRCA mutation-positive ovarian cancer market. However, high costs involved in genetic screening and low availability of geneticists may hamper growth of BRCA mutation-positive ovarian cancer market in future.

BRCA Mutation-Positive Ovarian Cancer Market: Overview

The global BRCA mutation-positive ovarian cancer market is estimated to show rapid growth over forecast period owing to increasing cases of ovarian cancer in females. BRCA mutation-positive ovarian cancer market has high potential due to development of latest drugs in near future for treating ovarian cancer. In addition, oral contraceptives are used as an adjuvant therapies in the BRCA mutation-positive ovarian cancer market. In 2017, FDA approved tablet form of Olaparib by Astrazeneca, which is used for maintenance treatment of ovarian cancer.

BRCA Mutation-Positive Ovarian Cancer Market: Regional Overview

The global BRCA mutation-positive ovarian cancer market is expected to be dominated by North America due to availability of reimbursements. Latin America market is emerging in BRCA mutation-positive ovarian cancer market due to increasing governmental spending on healthcare. Europe market is expected to be the second most growing region in the global BRCA mutation-positive ovarian cancer market owing to latest research and developmental activities.  BRCA mutation-positive ovarian cancer market in East Asia and South Asia is expected to show significant growth due to improving healthcare infrastructure. Middle East and Africa Market is expected to be least lucrative region in the BRCA mutation-positive ovarian cancer market due to poor healthcare facilities and less disease screening facilities.

BRCA Mutation-Positive Ovarian Cancer Market: Key Players

Examples of some of the market participants in BRCA Mutation-Positive Ovarian Cancer market identified across the value chain includes Astrazeneca plc, Merck & Co., Inc., Glaxosmithkline plc, Clovis Oncology, AbbVie Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Boehringer Ingelheim International GmbH,  F. Hoffmann-La Roche Ltd, and, others.

The research report on BRCA mutation-positive ovarian cancer market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and, statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on BRCA mutation-positive ovarian cancer market provides analysis and information according to market segments such as geographies, application, and end user.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11267

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com